Prothena Corporation plc Logo

Email this page: News Release

Prothena to Initiate PRONTO, a Global Trial of NEOD001 in Patients With AL Amyloidosis With Primary Endpoint of Cardiac Response

For security reasons, registration is required before you can use this feature.
* Indicates required field